| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|
Ribrag, Vincent
|
|
|
21 |
5 |
p. 309-317.e3
|
article
|
| 2 |
Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint
|
Rosenberg, Aaron S.
|
|
|
21 |
5 |
p. 345-354.e4
|
article
|
| 3 |
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
|
Shallis, Rory M.
|
|
|
21 |
5 |
p. e483-e487
|
article
|
| 4 |
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome
|
Morita, Kiyomi
|
|
|
21 |
5 |
p. 338-344
|
article
|
| 5 |
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy
|
Masarova, Lucia
|
|
|
21 |
5 |
p. 318-327.e6
|
article
|
| 6 |
Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders
|
Colak, Meryem
|
|
|
21 |
5 |
p. e488-e492
|
article
|
| 7 |
Editorial Board
|
|
|
|
21 |
5 |
p. A4-A5
|
article
|
| 8 |
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia
|
Parrondo, Ricardo D.
|
|
|
21 |
5 |
p. 355-360
|
article
|
| 9 |
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
|
Lancman, Guido
|
|
|
21 |
5 |
p. e470-e476
|
article
|
| 10 |
Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
|
Bazzell, Brian G.
|
|
|
21 |
5 |
p. 295-308
|
article
|
| 11 |
Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia
|
Phoompoung, Pakpoom
|
|
|
21 |
5 |
p. e477-e482
|
article
|
| 12 |
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment
|
Bellofiore, Claudia
|
|
|
21 |
5 |
p. e456-e459
|
article
|
| 13 |
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
|
Gómez García, Lara Maria
|
|
|
21 |
5 |
p. 328-337.e1
|
article
|
| 14 |
Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria
|
Fairchild, Andrew
|
|
|
21 |
5 |
p. e464-e469
|
article
|
| 15 |
Retrospective Analysis of the Impact of Adverse Event–Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies
|
Ma, Shuo
|
|
|
21 |
5 |
p. e432-e448
|
article
|
| 16 |
Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis
|
Hughes, David M.
|
|
|
21 |
5 |
p. e460-e463
|
article
|
| 17 |
Table of Contents
|
|
|
|
21 |
5 |
p. A6-A8, A10
|
article
|
| 18 |
Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia
|
Rausch, Johanna
|
|
|
21 |
5 |
p. e429-e431
|
article
|
| 19 |
Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence
|
Singh, Suvir
|
|
|
21 |
5 |
p. 289-294
|
article
|
| 20 |
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis
|
Kumar, Vivek
|
|
|
21 |
5 |
p. e449-e455
|
article
|
Journal description